Cell-penetrating Peptides: Efficient Vectors for Vaccine Delivery
- PMID: 30760185
- PMCID: PMC6637094
- DOI: 10.2174/1567201816666190123120915
Cell-penetrating Peptides: Efficient Vectors for Vaccine Delivery
Abstract
Subunit vaccines are composed of pathogen fragments that, on their own, are generally poorly immunogenic. Therefore, the incorporation of an immunostimulating agent, e.g. adjuvant, into vaccine formulation is required. However, there are only a limited number of licenced adjuvants and their immunostimulating ability is often limited, while their toxicity can be substantial. To overcome these problems, a variety of vaccine delivery systems have been proposed. Most of them are designed to improve the stability of antigen in vivo and its delivery into immune cells. Cell-penetrating peptides (CPPs) are especially attractive component of antigen delivery systems as they have been widely used to enhance drug transport into the cells. Fusing or co-delivery of antigen with CPPs can enhance antigen uptake, processing and presentation by antigen presenting cells (APCs), which are the fundamental steps in initiating an immune response. This review describes the different mechanisms of CPP intercellular uptake and various CPP-based vaccine delivery strategies.
Keywords: Cell-penetrating peptide; adjuvant; antigen presenting cells; antigen uptake; humoral and cellular immunity; vaccine delivery..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Figures



Similar articles
-
Cell-penetrating Peptide-mediated Nanovaccine Delivery.Curr Drug Targets. 2021;22(8):896-912. doi: 10.2174/1389450122666210203193225. Curr Drug Targets. 2021. PMID: 33538670 Review.
-
Cell-penetrating peptides as delivery enhancers for vaccine.Curr Pharm Biotechnol. 2014;15(3):256-66. doi: 10.2174/1389201015666140813130114. Curr Pharm Biotechnol. 2014. PMID: 25142954 Review.
-
Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity.Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2204078119. doi: 10.1073/pnas.2204078119. Epub 2022 Aug 1. Proc Natl Acad Sci U S A. 2022. PMID: 35914154 Free PMC article.
-
Cell-penetrating peptides mediated protein cross-membrane delivery and its use in bacterial vector vaccine.Fish Shellfish Immunol. 2014 Jul;39(1):8-16. doi: 10.1016/j.fsi.2014.04.003. Epub 2014 Apr 16. Fish Shellfish Immunol. 2014. PMID: 24746937
-
Uptake pathways of cell-penetrating peptides in the context of drug delivery, gene therapy, and vaccine development.Cell Signal. 2024 May;117:111116. doi: 10.1016/j.cellsig.2024.111116. Epub 2024 Feb 24. Cell Signal. 2024. PMID: 38408550
Cited by
-
Immunoinformatics Design of Multi-Epitope Peptide-Based Vaccine Against Schistosoma mansoni Using Transmembrane Proteins as a Target.Front Immunol. 2021 Mar 2;12:621706. doi: 10.3389/fimmu.2021.621706. eCollection 2021. Front Immunol. 2021. PMID: 33737928 Free PMC article.
-
Approaches for evaluation of novel CPP-based cargo delivery systems.Front Pharmacol. 2022 Oct 21;13:1056467. doi: 10.3389/fphar.2022.1056467. eCollection 2022. Front Pharmacol. 2022. PMID: 36339538 Free PMC article. Review.
-
POSEIDON: Peptidic Objects SEquence-based Interaction with cellular DOmaiNs: a new database and predictor.J Cheminform. 2024 Feb 16;16(1):18. doi: 10.1186/s13321-024-00810-7. J Cheminform. 2024. PMID: 38365724 Free PMC article.
-
Oral drug delivery for immunoengineering.Bioeng Transl Med. 2021 Aug 10;7(1):e10243. doi: 10.1002/btm2.10243. eCollection 2022 Jan. Bioeng Transl Med. 2021. PMID: 35111945 Free PMC article. Review.
-
Developments in Vaccine Adjuvants.Methods Mol Biol. 2022;2412:145-178. doi: 10.1007/978-1-0716-1892-9_8. Methods Mol Biol. 2022. PMID: 34918245 Review.
References
-
- Maurer D.M., Harrington B., Lane J.M. Smallpox vaccine: Contraindications, administration, and adverse reactions. Am. Fam. Physician. 2003;68:889–906. - PubMed
-
- Alonso P.L., Tanner M. Public health challenges and prospects for malaria control and elimination. Nat. Med. 2013;19:150. - PubMed
-
- Alm J.S., Lilja G., Pershagen G., Scheynius A. Early BCG vaccination and development of atopy. Lancet. 1997;350:400–403. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous